GlassScriptPhysician profile
Corie L Bevins
NPI 1245753268
$2,381.25
in general payments reported to CMS, 2019-2025
24 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.51 · 2022: $400 · 2023: $932 · 2024: $418 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Travel and Lodging: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.34 |
| Travel and Lodging | $228.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $665.75 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.87 | 2023-2025 | Jardiance |
| Getinge USA Sales, LLC | $365.97 | 2022-2023 | Vasoview Hemopro 2 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $313.37 | 2022-2025 | Lifevest |
| Edwards Lifesciences Corporation | $102.79 | 2023-2024 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Astrazeneca Pharmaceuticals LP | $48.45 | 2022-2023 | Tagrisso |
| Baxter Healthcare | $40.94 | 2023 | Perclot |
| Daiichi Sankyo INC. | $35.49 | 2023-2024 | Injectafer |
| United Therapeutics Corporation | $34.65 | 2024-2025 | Tyvaso, Tyvaso |
| Boston Scientific Corporation | $32.73 | 2023-2024 | Spaceoar Vue System - 10ml, Watchman Access System |
| Novo Nordisk INC | $30.00 | 2025 | Wegovy |
| Amgen INC. | $24.22 | 2021-2022 | |
| Inspire Medical Systems, INC. | $21.91 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $20.58 | 2023 | Definity |
| Heartflow, INC. | $19.75 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.86 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $16.01 | 2024 | Arcalyst |
| Pfizer INC. | $15.96 | 2025 | |
| Organogenesis INC. | $15.59 | 2022 | |
| Ethicon US, LLC | $15.22 | 2024 | Prolene, Vistaseal |
| Kiniksa Pharmaceuticals, LTD. | $14.59 | 2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $13.65 | 2023 | Opsumit, Uptravi |
| Cvrx, INC. | $12.16 | 2022 | |
| Lemaitre Vascular, INC. | $10.74 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corie Bevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.